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CLINICAL RESEARCH STUDIES
Treatment of ulcerative lesions of the heel
remains a challenging and often frustrating problem
for the vascular surgeon. The absence of available
soft tissue coverage in combination with the often
debilitated nature of this patient population makes
these lesions among the most difficult for which to
care. Although multiple reconstructive procedures
are available for soft tissue coverage of the chronic
heel lesion,1-3 their success is ultimately dependent
on the restoration of adequate local blood flow.4,5
Multiple reports have demonstrated pedal artery
bypass to be a durable and effective procedure for
limb salvage in the critically ischemic foot.6-13 Most
notably in the diabetic population, in which the dor-
salis pedis artery is usually spared of extensive ather-
osclerotic disease, restoration of pulsatile blood flow
to the foot has proven to be an effective treatment
for ulcerative or gangrenous lesions of the forefoot.
Less clear is the role of pedal artery bypass in the
treatment of ischemic lesions of the hindfoot.
Although a limited subgroup analysis of pedal bypass
has suggested poor limb salvage in the face of heel
ulcers,14 no detailed analysis of this difficult problem
has been performed. The current review draws on
our extensive experience with pedal artery revascu-
larization to examine its role in the treatment of
ischemic heel ulceration.
PATIENTS AND METHODS
From January 1990 to December 1995, 2213
infrainguinal bypass procedures were performed,
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evaluate the influence of an intact pedal arch on heel lesion healing.
Results: Complete healing rates for forefoot and heel lesions were similar (90.5% vs
86.5%, P = .26), with comparable rates of major lower extremity amputation (9.8% vs
9.3%, P = .87). Time to complete healing in the heel lesion group ranged from 13 to 716
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patients with heel lesions were independent of the presence of an intact arch, with heal-
ing rates of 90.2% and 83.7% (P = .38) and 2-year patency rates of 73.4% and 67.0% in
complete and incomplete pedal arches, respectively. Comparison of 5-year primary and
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67.2% versus 60.3% (P = .50), respectively.
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with 572 grafts using the dorsalis pedis artery as the
outflow vessel. This report specifically examines the
517 pedal bypasses that were placed for the indica-
tions of critical foot ischemia manifested by gan-
grene or a nonhealing ulcer. Patient data was
extracted from a computerized database in conjunc-
tion with review of the medical records.
Patients were selected for operation on the basis
of the presence of severe tibial disease in association
with ischemic ulceration or gangrene limited to the
heel or forefoot. Lesions of the heel were defined as
tissue loss inferior to the malleoli and overlying the
calcaneous, and forefoot lesions consisted of tissue
loss overlying the metatarsal heads or more distally.
Patients with ischemic soft tissue breakdown
between the calcaneous and metatarsal heads (plan-
tar region) were excluded from further analysis.
Digital angiography was performed preopera-
tively to assess available revascularization options.
Short bypasses originating from the popliteal artery
were performed when angiographic studies excluded
significant proximal occlusive disease. The dorsalis
pedis artery was chosen as the outflow vessel when
no tibial vessels were in direct continuity with the
foot. Biplanar views of the foot were obtained to
clearly demonstrate the pedal anatomy.
Patients discharged with patent grafts were seen in
follow-up at 2 weeks, then every 3 months for 1 year,
and then at 6- to 12-month intervals. Additionally,
patients with open wounds were seen at 2-week inter-
vals until the wounds were healed. Graft patency was
determined by the presence of a palpable graft or dor-
salis pedis artery pulse. Patient survival was verified
through a search performed by using the Social
Security Death Index. Primary and secondary paten-
cy, limb salvage, and patient survival were analyzed by
the life-table method by using standardized reporting
criteria.15 Life tables were compared by log-rank test-
ing. Patient characteristics, graft characteristics, heal-
ing rates, and complication rates were compared
between groups with c 2 analysis.
To assess the role of an intact pedal arch in ulcer
healing, available preoperative angiograms for
patients in the heel lesion group were retrospective-
ly reviewed to assess for a connection between the
dorsal and plantar circulation of the foot. Patency of
the dorsalis pedis from its origin to the lateral plan-
tar through the deep plantar artery was considered
as an intact pedal arch.
RESULTS
Five hundred seventeen consecutive pedal artery
grafts were available for analysis. Patients in whom
the location of tissue loss could not be accurately
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Table I. Patient demographics
Forefoot ulcers (n = 336) Heel ulcers (n = 96) P value
Mean age (y) 65.1 67.5 .21
Sex (male) 72.6% 64.6% .13
Indications for surgery
Ulcer 89.2% 95.8% .05
Gangrene 40.0% 25.0% .01
Cellulitis 18.0% 11.5% .13
Previous operations
Infrainguinal bypass 32.3% 35.8% .53
Aorto-iliac bypass 1.5% 2.11% .75
Carotid endarterectomy 5.4% 8.4% .27
Major leg amputation 5.4% 7.4% .71
Preoperative risk factors
Diabetes 95.5% 90.6% .07
Tobacco use
Current 12.1% 18.3% .14
Former 62.3% 49.0% .02
Coronary artery disease
History of congestive heart failure 16.0% 28.2% .01
Angina 8.3% 13.8% .11
Previous myocardial infarction 31.6% 32.7% .85
Previous coronary revascularization 21.0% 19.0% .66
Hypertension 59.3% 65.6% .27
Renal disease
Serum creatinine >2.0 12.1% 17.7% .15
Hemodialysis 4.5% 9.4% .07
Renal transplant 1.5% 2.1% .69
determined (n = 39) and in whom ulcer healing
could not be followed for greater than 3 months (n
= 40) were excluded from the analysis. Of the 79
patients who were excluded from further analysis, 13
patients (16%) experienced primary graft occlusions
ranging from 1 to 29 months, with five of these
occlusions occurring within 1 month and an addi-
tional three occurring within 6 months of the initial
operation.
As such, we reviewed the results of 336 patients
who underwent pedal bypass for forefoot lesions, 67
patients who underwent revascularization for isolat-
ed heel lesions, and 29 patients who underwent
revascularization for both forefoot and heel tissue
loss. For subsequent analyses, patients with com-
bined forefoot and heel lesions were included in the
heel lesion group. Review of these 29 patients
demonstrated no significant difference from those
patients with isolated heel lesions. Additionally, six
patients with isolated plantar ulcers were excluded
from the analysis. Within this latter group, three of
the six patients did not demonstrate complete heal-
ing during the study period, with one patient ulti-
mately requiring a major amputation.
Preoperative patient characteristics and athero-
sclerotic risk factors for the forefoot and heel lesion
groups are summarized in Table I. Groups were sim-
ilar with regard to sex and age. Not unexpectedly,
preoperative indications for surgery differed
between the two groups, with a higher proportion
of gangrene in the forefoot lesions and a higher inci-
dence of ulceration in the heel lesions. The incidence
of previous infrainguinal or aorto-iliac bypass,
carotid endarterectomy, or major limb amputation
was similar between the groups. Vascular risk factors
were notable for a greater incidence of former smok-
ers in the forefoot group and patients with a history
of congestive heart failure in the heel group.
Table II summarizes the graft characteristics for
each patient group. Greater than 40% of the grafts
originated from the below-knee popliteal position,
and this was comparable in both groups. The next
most common sites of inflow were the common
femoral, above-knee popliteal, and superficial
femoral arteries, respectively. Inflow from a previ-
ously placed vein or prosthetic graft was only used
4% of the time.
The conduit of choice was the greater saphenous
vein, being equally used in an in situ, reversed, or
nonreversed configuration. An arm vein was used in
8.7% of the cases, whereas a composite vein graft
(with or without prosthetic material) was used 8.6%
of the time. No significant differences in the type of
conduit were noted between the two groups.
Life-table analysis for primary and secondary
patency of the entire dorsalis pedis artery bypass
experience (Tables III and IV) demonstrates 5-year
primary and secondary patency rates of 61.6% and
66.8%, respectively. Focusing on the subset of
patients with ischemic foot lesions, 6-year primary
and secondary graft patency, limb salvage rates, and
patient survival for the forefoot and heel lesion
groups are presented in life-table format in Figs 1
and 2. Error bars represent the standard error for
each data point, and the dashed line illustrates the
portion of the curve where the standard error
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Table II. Graft characteristics
Forefoot ulcers (n = 336) Heel ulcers (n = 96) P value
Inflow vessel
External iliac artery 0.6% 0.0% .44
Common femoral artery 25.6% 30.2% .37
Superficial femoral artery 12.2% 8.3% .29
Profunda femoris artery 0.3% 0.0% .59
Above-knee popliteal artery 13.4% 9.4% .29
Below-knee popliteal artery 42.0% 46.9% .39
Tibial artery 0.6% 1.0% .64
Vein graft 4.8% 3.1% .49
Prosthetic graft 0.6% 1.0% .64
Conduit
In situ saphenous vein 27.1% 27.1% .99
Reversed saphenous vein 28.9% 20.8% .12
Nonreversed saphenous vein 26.8% 35.4% .10
Arm vein 8.9% 6.3% .40
Composite vein 6.3% 8.3% .47
Composite vein/PTFE 2.1% 2.1% .99
Sequential graft 4.8% 2.1% .25
PTFE, Polytetrafluoroethylene.
exceeds 10%. Comparison of 1- and 5-year primary
patency rates between the forefoot and heel lesion
groups demonstrated no significant difference, with
patency rates of 80.5% versus 80.2% (P = .95) and
56.9% versus 62.1% (P = .57), respectively. Secondary
patency was restored in 30 grafts (8.9%) in the fore-
foot lesion group and 7 grafts (7.3%) in the heel
lesion group. The most common graft successfully
revised was the popliteal to dorsalis pedis artery graft
(20 patients), with patency restored with a proximal
jump graft from the common or superficial femoral
artery in 10 patients, vein patch angioplasty for a
midgraft stenosis in 5 patients, and revision of the
distal anastomosis in 4 patients. The resulting sec-
ondary patency rates at 1 and 5 years were essential-
ly identical between the groups (84.8% vs 84.5% [P =
.94] and 67.2% vs 60.3% [P = .50] forefoot vs heel
lesions, respectively).
Healing rates for the forefoot and heel lesion
groups are provided in Table V. Complete healing of
the initiating foot lesion was comparable in the two
groups, with healing in 304 of 336 patients (90.5%)
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Fig 1. Cumulative primary patency, secondary patency, limb salvage rate, and patient survival
for forefoot lesions.
with forefoot lesions and 84 of 96 patients (86.5%)
with heel lesions. The mean time to complete heal-
ing was 139 days, with the distribution of healing
times shown in Fig 3. Of the 12 heel lesions that
failed to heal, six grafts were patent at the comple-
tion of the study period, and six grafts had failed.
Within the subgroup of six occluded grafts, five
limbs ultimately required major amputations, where-
as among the six patent grafts, two limbs required
amputation. Comparing the rates of amputation for
the forefoot versus heel lesion groups, no significant
difference was noted in either above-knee amputa-
tions (0.9% vs 1.0%, P = .89) or below-knee ampu-
tations (8.9% vs 8.3%, P = .86). These findings were
confirmed by the limb salvage life tables (Figs 1 and
2), in which 1- and 5-year limb salvage rates were
94.2% versus 93.5% (P = .81) and 87.4% versus
89.4% (P = .60) for forefoot versus heel lesions,
respectively. Limb salvage was aided by the use of
limited procedures on the foot. Minor amputations
were used extensively in the forefoot lesion group
(162 of 336 patients), whereas a variety of other
local procedures were primarily used in the heel
lesion group (21 of 96 patients). The frequency of
each of these individual procedures is provided in
Table V. Of note, one patient with extensive heel
ulceration underwent myocutaneous rotation flap
closure of the defect, resulting in successful healing
of the lesion.
Eighty-four angiograms (89%) were available in
the heel lesion group to evaluate for the presence of
an intact pedal arch. Forty-one patients (48.8%)
demonstrated continuity between the dorsal and
plantar circulation through the deep plantar artery.
Healing rates of heel lesions were independent of
the presence or absence of an intact pedal arch, with
90.2% healing in patients with a complete arch and
83.7% in patients with an incomplete arch (P = .38).
Primary patency rates for patients with a complete or
incomplete pedal arch were also similar (Fig 4), with
1- and 2-year patency rates of 76.6% versus 83.4%
and 73.4% versus 67.0%, respectively.
Table VI lists the 30-day systemic and local com-
plications encountered in this series. Most frequent
were local wound complications, ranging from local
cellulitis to wound dehiscence. Two perioperative
deaths occurred in the forefoot lesion group, and
none occurred in the heel lesion group, leading to
an overall perioperative mortality rate of 0.5%.
DISCUSSION
Management of heel lesions continues to be a
difficult problem, such that patients with severe heel
ulcerations are often treated with primary amputa-
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Table III. Primary patency life-table analysis of all dorsalis pedis artery grafts
No. of grafts No. of No. withdrawn Interval patency Cumulative Standard
Internal (mo) at risk at start failed grafts patent rate patency (%) error (%)
0-1 538 32 30 0.94 100 1.0
1-3 476 22 35 0.95 94 1.3
3-6 419 27 42 0.93 89 1.7
6-9 350 11 20 0.97 83 1.9
9-12 319 5 30 0.98 81 2.0
12-15 284 9 19 0.97 79 2.2
15-18 256 2 22 0.99 77 2.3
18-21 232 5 26 0.98 76 2.5
21-24 201 2 18 0.99 74 2.7
24-27 181 0 20 1.00 74 2.8
27-30 161 2 21 0.99 74 3.0
30-33 138 4 19 0.97 73 3.3
33-36 115 1 15 0.99 70 3.6
36-39 99 3 11 0.97 70 3.9
39-42 85 1 14 0.99 67 4.2
42-45 70 0 9 1.00 67 4.6
45-48 61 0 8 1.00 67 4.9
48-51 53 0 7 1.00 67 5.3
51-54 46 2 7 0.95 67 5.7
54-57 37 1 4 0.97 63 6.3
57-60 32 1 12 0.96 62 6.7
60-63 19 0 5 1.00 59 8.7
63-66 14 0 4 1.00 59 10.1
66-69 10 0 1 1.00 59 12.0
69-72 9 0 2 1.00 59 12.6
72-85 7 1 6 0.75 59 12.5
tion. The combination of distal neuropathy, repeat-
ed local trauma, prolonged periods of decubitus
pressure, and peripheral arterial disease make these
lesions particularly problematic in the diabetic pop-
ulation. This is supported by the greater than 90%
prevalence of diabetic subjects in the heel lesion
study group of the current report.
Although many reconstructive options are avail-
able for the treatment of heel ulcers,1-3 cornerstone to
their management is the restoration of adequate arte-
rial blood flow to the affected region.4,5 Although
direct revascularization of the hindfoot by means of
the posterior tibial artery is often an attractive option,
its use is frequently limited, especially in the diabetic
population, by significant tibial atherosclerosis.6,16,17
Alternatively, blood flow to the foot may be restored
by means of the dorsal circulation, with perfusion of
the hindfoot provided through collateral pathways.18
The current study draws on our large experience with
inframalleolar revascularization to examine the role of
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Fig 2. Cumulative primary patency, secondary patency, limb salvage rate, and patient survival
for heel lesions.
dorsalis pedis artery bypass in the treatment of
ischemic heel lesions.
One- and five-year patency rates for grafts placed
to the dorsalis pedis artery were independent of the
location of the lesion. With primary 5-year patency
rates ranging between 55% and 60% and secondary
patency rates between 60% and 70%, these findings
are in agreement with both our previously published
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 3 Berceli et al 505
Table IV. Secondary patency life-table analysis of all dorsalis pedis artery grafts
No. of grafts No. of No. withdrawn Interval patency Cumulative Standard
Internal (mo) at risk at start failed grafts patent rate patency (%) error (%)
0-1 538 19 30 0.96 100 0.8
1-3 489 18 35 0.96 96 1.1
3-6 436 21 46 0.95 93 1.5
6-9 369 9 22 0.97 88 1.7
9-12 338 5 32 0.98 86 1.8
12-15 301 6 20 0.98 84 2.0
15-18 275 2 22 0.99 83 2.1
18-21 251 5 27 0.98 82 2.2
21-24 219 2 21 0.99 80 2.4
24-27 196 1 21 0.99 80 2.6
27-30 174 2 22 0.99 79 2.8
30-33 150 3 21 0.98 78 3.0
33-36 126 1 18 0.99 76 3.3
36-39 107 3 12 0.97 76 3.7
39-42 92 1 14 0.99 74 4.0
42-45 77 0 9 1.00 73 4.3
45-48 68 0 9 1.00 73 4.6
48-51 59 1 7 0.98 73 5.0
51-54 51 3 9 0.94 71 5.4
54-57 39 0 4 1.00 67 6.2
57-60 35 0 13 1.00 67 6.5
60-63 22 0 5 1.00 67 8.2
63-66 17 0 5 1.00 67 9.3
66-69 12 0 1 1.00 67 11.1
69-72 11 0 2 1.00 67 11.6
72-85 9 1 8 0.80 67 12.2
Fig 3. Frequency distribution of time for complete healing of heel lesions.
data6,7 and those data provided by other groups.8-13
Although these grafts are now widely recognized as
providing adequate and durable treatment for limb-
threatening forefoot ischemia, their efficacy in the
treatment of hindfoot ischemia has not been system-
atically addressed. With healing rates approaching
90% for heel lesions, our data demonstrate that dor-
salis pedis bypass effectively reverses local hindfoot
ischemia to promote tissue healing. This finding is
supported by a greater than 85% 5-year limb salvage
rate for both forefoot and heel lesions.
Clinical presentation of ischemic heel lesions
can extend over a wide spectrum of pathologies,
ranging from localized skin fissures extending into
the dermis to extensive necrosis of subcutaneous
tissues and Achilles tendon with underlying cal-
caneal osteomyelitis. Of the 96 patients with heel
lesions reviewed in the current series, the relative
early nature of the lesions is illustrated by the need
for operative debridement or reconstruction in
only 23%. Those patients not requiring local heel
procedures were treated with local wound care,
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Fig 4. Cumulative primary patency rates for patients with heel lesions demonstrating a com-
plete or incomplete pedal arch.
packing of open wounds with normal saline or one-
quarter strength povodine-iodine solution, and
systemic antibiotics as indicated. Of these 75
patients with limited tissue loss, 88% demonstrated
complete healing of their lesion. In the 21 patients
with more extensive tissue loss requiring operative
intervention, initial treatment consisted of prompt
drainage of deep space infections with local wound
care as described above. After revascularization in
these patients, soft tissue coverage was obtained by
means of a variety of procedures. If the lesions
demonstrated a healthy granulation bed overlying
the calcaneous, split thickness skin grafting over
the defect was performed. With lesions demon-
strating evidence of calcaneal exposure and pre-
sumed osteomyelitis, primary therapy consisted of
partial calcanectomy with primary closure of the
wound. If the extent of skin loss was too extensive
for primary closure, skin edges were approximated
with retention sutures, and the remaining defect
was allowed to heal by secondary intention. Direct
skin grafting to an exposed calcaneous or use of
radiologic testing for the diagnosis of osteomyelitis
were not used in these patients. Soft tissue defects
too large for approximation after calcanectomy
were treated with myocutaneous grafts. Of the 21
patients who underwent operative debridement
and reconstruction, complete healing of their
lesions was accomplished in 81%.
Although no direct comparison of our findings to
previous studies are available, the influence of chron-
ic heel ulcerations on limb salvage was addressed in
the subgroup analysis of Carsten et al.14 In reviewing
191 infrainguinal bypasses, they determined that 5 of
17 major amputations that were performed despite a
patent graft resulted from chronic neuropathic heel
ulcers. This is in contrast to our series of 432 dorsalis
pedis bypasses in which only two patients with non-
healing heel lesions and patent grafts ultimately
required amputation.
The difficult problem of heel ulceration in the
diabetic patient with peripheral vascular disease is
illustrated by the data of Smith et al.3 Thirteen of
twenty-three (57%) patients required an average of
33 weeks after arterial bypass to completely heal
their lesions. Six patients (26%) in their study coex-
isted with some wound areas remaining open, and
two patients (9%) required amputation. Although
our 90% healing rate, with an average time to heal-
ing of 20 weeks, is an improvement over these find-
ings, we report a similar 10% major amputation rate.
The status of the pedal arch and its contribution to
outflow resistance (and secondarily pedal graft paten-
cy) remains an area of controversy.8,17-19 Less well
studied is the influence of an intact pedal arch on heel
lesion healing, notably after placement of a dorsalis
pedis bypass graft. Our data demonstrate that both
graft patency and lesion healing are not dependent on
the angiographic presence of a complete arch. As such,
results of this study would argue that in the absence of
an intact pedal arch, sufficient collateral pathways are
present to revascularize the heel after restoration of
pulsatile flow to the forefoot circulation.
In conclusion, although heel lesions remain a dif-
ficult problem in the care of vascular patients, dor-
salis pedis artery revascularization serves as a useful
adjunct to their treatment. With pedal artery bypass
in association with adequate local debridement,
aggressive wound care, and reconstructive proce-
dures when indicated, healing and limb salvage rates
for heel lesions can approximate those seen with
forefoot lesions.
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